![Michael Dutra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Dutra
Investitore di Private Equity presso
Hercules Capital
Profilo
Mike Dutra is a Managing Director in the Life Sciences Group working in the Boston office.
He is focused on transactions with a broad range of private and public healthcare companies including biotechnology, specialty pharmaceuticals, medical device, innovative services, and other healthcare companies at all stages of development.
Mike joined Hercules in June 2014 and was most recently promoted to Managing Director in January 2021.
Prior to Hercules, he held positions with Goldman Sachs as an Operations Analyst and with DePuy Synthes as a Quality Engineer.
Mike graduated with honors from Northeastern University with a B.S.
in Industrial Engineering.
Posizioni attive di Michael Dutra
| Società | Posizione | Inizio |
|---|---|---|
Hercules Capital
 Hercules Capital Investment ManagersFinance Hercules Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of technology and life science sectors. It provides financing in the form of debt and equity for acquisitions, growth stage capital requirements with a transaction size ranging from USD 5 to 500 million. | Investitore di Private Equity | 01/01/2019 |
Formazione di Michael Dutra
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
82
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hercules Capital
Hercules Capital Investment ManagersFinance Hercules Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of technology and life science sectors. It provides financing in the form of debt and equity for acquisitions, growth stage capital requirements with a transaction size ranging from USD 5 to 500 million. | Finance |
